|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 BGN | -0.57% |
|
-0.57% | +1.76% |
Tchaikapharma High Quality Medicines AD reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was BGN 0.106 million compared to BGN 0.021 million a year ago. Revenue was BGN 23 million compared to BGN 22.33 million a year ago.
Net income was BGN 2.59 million compared to BGN 2.72 million a year ago. Basic earnings per share from continuing operations was BGN 0.0285 compared to BGN 0.0285 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.76% | 839M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
TCHAIKAPHARMA HIGH QUALITY MEDICINES AD 
